CUSIP 92686J106COMVKTXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
419 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Vanguard Group Inc | 9.98M | $351.25M | −14.6K | Reduced |
| 2 | Blackrock, Inc. | 6.61M | $232.61M | +1.02M | Added |
| 3 | Fmr LLC | 6.56M | $230.70M | +767.7K | Added |
| 4 | State Street Corp | 4.45M | $156.39M |
| Reduced |
| 5 | Morgan Stanley | 3.08M | $108.22M | −652.8K | Reduced |
| 6 | Two Sigma Investments, LP | 2.44M | $85.69M | +350.3K | Added |
| 7 | Two Sigma Advisers, LP | 2.13M | $74.91M | +574.1K | Added |
| 8 | Geode Capital Management, LLC | 1.99M | $70.18M | +385.9K | Added |
| 9 | Citadel Advisors LLC | 1.73M | $60.95M | −165.9K | Reduced |
| 10 | D. E. Shaw & Co., Inc. | 1.72M | $60.46M | +1.56M | Added |
See every fund holding Viking Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders